184 related articles for article (PubMed ID: 9529655)
1. B cell superantigens: possible roles in immunodeficiency and autoimmunity.
Silverman GJ
Semin Immunol; 1998 Feb; 10(1):43-55. PubMed ID: 9529655
[TBL] [Abstract][Full Text] [Related]
2. The dual phases of the response to neonatal exposure to a VH family-restricted staphylococcal B cell superantigen.
Silverman GJ; Nayak JV; Warnatz K; Hajjar FF; Cary S; Tighe H; Curtiss VE
J Immunol; 1998 Nov; 161(10):5720-32. PubMed ID: 9820554
[TBL] [Abstract][Full Text] [Related]
3. Age-associated changes in binding of human B lymphocytes to a VH3-restricted unconventional bacterial antigen.
Silverman GJ; Sasano M; Wormsley SB
J Immunol; 1993 Nov; 151(10):5840-55. PubMed ID: 7693819
[TBL] [Abstract][Full Text] [Related]
4. A model B-cell superantigen and the immunobiology of B lymphocytes.
Silverman GJ; Goodyear CS
Clin Immunol; 2002 Feb; 102(2):117-34. PubMed ID: 11846453
[TBL] [Abstract][Full Text] [Related]
5. Unconventional B-cell antigens and human immune repertoires.
Silverman GJ
Ann N Y Acad Sci; 1995 Sep; 764():342-55. PubMed ID: 7486544
[No Abstract] [Full Text] [Related]
6. An endogenous sialoprotein and a bacterial B cell superantigen compete in their VH family-specific binding interactions with human Igs.
Silverman GJ; Pirès R; Bouvet JP
J Immunol; 1996 Nov; 157(10):4496-502. PubMed ID: 8906827
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of B-cell superantigen-induced immune complex-mediated inflammation.
Anderson AL; Sporici R; Lambris J; Larosa D; Levinson AI
Infect Immun; 2006 Feb; 74(2):1196-203. PubMed ID: 16428769
[TBL] [Abstract][Full Text] [Related]
8. Activation of self-reactive B cells and autoimmune diseases.
Burrows PD; Suematsu S; Watanabe T
Rev Immunogenet; 2000; 2(1):38-51. PubMed ID: 11324692
[TBL] [Abstract][Full Text] [Related]
9. Exploitation of host signaling pathways by B cell superantigens--potential strategies for developing targeted therapies in systemic autoimmunity.
Zouali M
Ann N Y Acad Sci; 2007 Jan; 1095():342-54. PubMed ID: 17404047
[TBL] [Abstract][Full Text] [Related]
10. Confounding B-cell defences: lessons from a staphylococcal superantigen.
Silverman GJ; Goodyear CS
Nat Rev Immunol; 2006 Jun; 6(6):465-75. PubMed ID: 16724100
[TBL] [Abstract][Full Text] [Related]
11. B cell superantigens subvert innate functions of B cells.
Zouali M
Chem Immunol Allergy; 2007; 93():92-105. PubMed ID: 17369702
[TBL] [Abstract][Full Text] [Related]
12. B-cell superantigens: implications for selection of the human antibody repertoire.
Zouali M
Immunol Today; 1995 Aug; 16(8):399-405. PubMed ID: 7546197
[TBL] [Abstract][Full Text] [Related]
13. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
[TBL] [Abstract][Full Text] [Related]
14. In vivo consequences of B cell superantigen immunization.
Silverman GJ; Nayak JV; Wagenknecht R; Warnatz K
Ann N Y Acad Sci; 1997 Apr; 815():105-10. PubMed ID: 9186643
[No Abstract] [Full Text] [Related]
15. B-cell tolerance checkpoints in health and autoimmunity.
Meffre E; Wardemann H
Curr Opin Immunol; 2008 Dec; 20(6):632-8. PubMed ID: 18848883
[TBL] [Abstract][Full Text] [Related]
16. Censoring of autoreactive B cell development by the pre-B cell receptor.
Keenan RA; De Riva A; Corleis B; Hepburn L; Licence S; Winkler TH; Mårtensson IL
Science; 2008 Aug; 321(5889):696-9. PubMed ID: 18566249
[TBL] [Abstract][Full Text] [Related]
17. In vivo inflammatory response to a prototypic B cell superantigen: elicitation of an Arthus reaction by staphylococcal protein A.
Kozlowski LM; Li W; Goldschmidt M; Levinson AI
J Immunol; 1998 Jun; 160(11):5246-52. PubMed ID: 9605120
[TBL] [Abstract][Full Text] [Related]
18. B-cell superantigens: definition and potential impact on the immune response.
Levinson AI; Kozlowski L; Zheng Y; Wheatley L
J Clin Immunol; 1995 Nov; 15(6 Suppl):26S-36S. PubMed ID: 8613489
[TBL] [Abstract][Full Text] [Related]
19. A B-cell superantigen that targets B-1 lymphocytes.
Silverman GJ; Cary S; Graille M; Curtiss VE; Wagenknecht R; Luo L; Dwyer D; Goodyear C; Corper AL; Stura EA; Charbonnier JB
Curr Top Microbiol Immunol; 2000; 252():251-63. PubMed ID: 11125483
[No Abstract] [Full Text] [Related]
20. Complement activation by a B cell superantigen.
Kozlowski LM; Soulika AM; Silverman GJ; Lambris JD; Levinson AI
J Immunol; 1996 Aug; 157(3):1200-6. PubMed ID: 8757626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
